Market Cap 66,000.00
Revenue (ttm) 1.56M
Net Income (ttm) -880,000.00
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -56.41%
Debt to Equity Ratio 0.00
Volume 600
Avg Vol 7,044
Day's Range N/A - N/A
Shares Out 66.50M
Stochastic %K 15%
Beta -1.96
Analysts Strong Buy
Price Target $6.00

Company Profile

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, si...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 847 705 7709
Fax: 847 705 5399
Address:
616 N. North Court, Suite 120, Palatine, United States
Diretoban
Diretoban Jun. 11 at 10:43 AM
$ACUR https://www.pharmacytimes.com/view/because-ned-said-new-technology-helps-prevent-opioid-overdose
0 · Reply
SenMars
SenMars Feb. 11 at 12:32 AM
0 · Reply
EarningsInsider
EarningsInsider Aug. 16 at 3:30 PM
Acura Pharmaceuticals, Inc. Files SEC Form 8-K $ACUR https://www.marketbeat.com/stocks/OTCMKTS/ACUR/sec-filings/
0 · Reply
Latest News on ACUR
No data available.
Diretoban
Diretoban Jun. 11 at 10:43 AM
$ACUR https://www.pharmacytimes.com/view/because-ned-said-new-technology-helps-prevent-opioid-overdose
0 · Reply
SenMars
SenMars Feb. 11 at 12:32 AM
0 · Reply
EarningsInsider
EarningsInsider Aug. 16 at 3:30 PM
Acura Pharmaceuticals, Inc. Files SEC Form 8-K $ACUR https://www.marketbeat.com/stocks/OTCMKTS/ACUR/sec-filings/
0 · Reply